Medical Devices Startups

Pharmaron provides drug research and development services globally, supporting the discovery and development of pharmaceutical therapies through integrated capabilities across multiple geographic regions.

1 investor

Zylox-Tonbridge Medical is a Chinese medical device company developing clinical solutions and products, with a focus on neurovascular and peripheral vascular interventional treatments. It is publicly listed on the Hong Kong Stock Exchange (02190.HK).

1 investor

Stonewise builds an AI-powered small-molecule drug design platform using multimodal 3D molecular generation models for pharmaceutical research and development. The company leverages molecular dynamics simulation and machine learning to assist drug discovery teams in structure analysis and molecular information extraction.

1 investor

aceRNA Technologies develops therapies based on RNA technology, focusing on the discovery of new functions of miRNA to contribute to regenerative medicine and the creation of new drugs for diseases that currently lack treatments. The company operates in the biotech and drug discovery field.

1 investor

Amidex develops Amidex®, a digital index (template) system for composite resin dental treatment that lets dentists restore and reshape teeth with minimal cutting of healthy tooth structure. The company targets dental clinics, aiming to standardize low-invasive restorative dentistry across Japan.

1 investor

A company founded in June 2021 by a technology executive with a background in fintech and mobile platforms. The page provides an executive's career biography but does not describe the company's product or service.

1 investor

Arktus Therapeutics develops regenerative medicine treatments derived from iPS cells, initially focusing on knee joint diseases with plans to expand to additional organ systems. The company brings together clinical, research, and regulatory expertise to advance innovative cell-based therapeutic products.

1 investor

Ayumo develops a gait analysis device designed by orthopedic physicians to support people with walking difficulties in receiving early appropriate treatment and improving motor function.

1 investor

HikariQ Health develops innovative immunoassay methods and antibody therapeutics using proprietary Q-body technology, a fluorescence quenching-based antibody modification technique. The company targets pharmaceutical and medical applications to improve healthcare diagnostics and therapeutics globally.

1 investor

HIROTSUS Bioscience develops N-NOSE, a cancer screening test that uses nematodes to detect trace odor markers in urine samples, enabling early cancer detection. The company operates in medical diagnostics and contributes to public health through research and development.

1 investor

KORTUC develops a cancer radiotherapy (code name KRC-01) that uses hydrogen peroxide as a radiosensitizer to treat solid tumors. The company operates in the biopharmaceutical and radiation oncology space.

1 investor

Liquid Mine develops MyRD®, a liquid biopsy-based genomic testing system that creates personalized diagnostic tests for leukemia and other cancers by analyzing individual patient genetic mutations. The company aims to advance precision medicine in oncology by making genomic testing more accessible, particularly in Japan, through collaboration with Tokyo University's Institute of Medical Science.

1 investor

Onodera develops AAV vector platforms for gene therapy research targeting neurological conditions. The company owns proprietary AAV vector patents, enabling internal development of therapeutic vectors without licensing costs from third parties.

1 investor

TearExo develops a cancer detection method that analyzes exosomes in tears, aiming for a painless, non-invasive test to assess breast cancer risk and support early detection. Spun out of Kobe University in Japan, the company targets clinical screening as an alternative to blood-based and mammography testing.

1 investor

Veqta is a company that conducts genetic and health testing for pets, including dog age determination, breed identification, and disease screening. The company also offers contract research and development services for pet food evaluation, animal health monitoring devices, and veterinary solutions.

1 investor

xCARE operates a talent platform and project management service specialized for the medical industry, connecting external professional experts with pharmaceutical, medical device, and other medical product development projects. The Japan-based company aims to help startups and academic projects bring medical products to market by supplying needed specialists on a flexible basis.

1 investor

Oligogen is a Japanese biotech venture focused on regenerative medicine and drug discovery, conducting novel research and development in the pharmaceutical field.

1 investor

CareNet is a medical platform provider serving physicians and healthcare professionals in Japan with clinical information, medical education content, and pharmaceutical marketing support tools. The company operates a membership-based ecosystem including medical news sites, video platforms, and data analytics services for the healthcare industry.

1 investor

Southwood Inc. manufactures and sells medical devices and medical AI products for healthcare professionals. The company holds Japanese regulatory approvals for medical device manufacturing and distribution.

1 investor

Space Bio-Laboratories develops regenerative medicine technologies and medical devices combining biotech with robotics, including gravity control systems for cell culture and walking assistance devices. The company targets incurable diseases like stroke, spinal cord injury, and myocardial infarction through advanced biotech research and rehabilitation solutions.

1 investor

Transgenic provides mice and related genetic research products, including frozen embryos, knockout mouse libraries, plasmid DNA products, and phenotype databases for academic and research institutions conducting basic life sciences research.

1 investor

RealVision Inc. develops specialized graphics solutions for medical monitors, air traffic control systems, and amusement equipment applications. The company serves government agencies, healthcare organizations, and entertainment venues in Japan.

1 investor

ReEir is a Japanese company founded out of regenerative medicine and wound-care expertise, working in areas such as regenerative medicine, wound surgery, and foot/podiatric care. It is led by academics and industry figures with backgrounds in plastic surgery, regenerative medicine, and medical devices.

1 investor

Stem Cell & Device Laboratory (SCAD) commercializes pluripotent stem cell (ES/iPS) research from Kyoto University, developing cell and tissue products that combine stem cell technology with material and device technology. Its products are aimed at drug discovery assays and regenerative medicine, serving pharmaceutical and life science companies.

1 investor